+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Drug"

Single Use Downstream Bioprocessing Market (2nd Edition) by Type of Product, Scale of Operation, End User, and Geographical Regions - Trends and Forecast Till 2035 - Product Thumbnail Image

Single Use Downstream Bioprocessing Market (2nd Edition) by Type of Product, Scale of Operation, End User, and Geographical Regions - Trends and Forecast Till 2035

  • Report
  • June 2026
  • 222 Pages
  • Global
From
Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals, Development Platforms & Market Opportunity Insight 2026 - Product Thumbnail Image

Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals, Development Platforms & Market Opportunity Insight 2026

  • Report
  • April 2026
  • 240 Pages
  • Global
From
Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026 - Product Thumbnail Image

Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026

  • Report
  • April 2026
  • 100 Pages
  • Global
From
Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031 - Product Thumbnail Image

Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031

  • Report
  • March 2026
  • 960 Pages
  • Global
From
Trispecific Antibodies Market Opportunity, Proprietary Technologies & Clinical Trials Insight 2026 - Product Thumbnail Image

Trispecific Antibodies Market Opportunity, Proprietary Technologies & Clinical Trials Insight 2026

  • Report
  • February 2026
  • 210 Pages
  • Global
From
CD137 Targeted Therapy Market Opportunity, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insight 2026 - Product Thumbnail Image

CD137 Targeted Therapy Market Opportunity, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insight 2026

  • Report
  • January 2026
  • 270 Pages
  • Global
From
Claudin18.2 Targeted Therapy Market Opportunity, Therapeutic Approaches, Approved Drug Price, Sales and Clinical Trials Insight 2030 - Product Thumbnail Image

Claudin18.2 Targeted Therapy Market Opportunity, Therapeutic Approaches, Approved Drug Price, Sales and Clinical Trials Insight 2030

  • Report
  • January 2026
  • 240 Pages
  • Global
From
Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026 - Product Thumbnail Image

Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026

  • Report
  • November 2025
  • 120 Pages
  • Global
From
TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026 - Product Thumbnail Image

TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026

  • Report
  • November 2025
  • 160 Pages
  • Global
From
Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031 - Product Thumbnail Image

Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031

  • Report
  • June 2026
  • 765 Pages
  • Global
From
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030 - Product Thumbnail Image

Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030

  • Report
  • October 2025
  • 309 Pages
  • Global
From
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035 - Product Thumbnail Image

Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035

  • Report
  • September 2025
  • 313 Pages
  • Global
From
Tangential Flow Filtration Market by Product (Single Use Systems, Cassettes, Capsules), Material (PES, PVDF), Technique (Ultrafiltration), Application (Protein, Vaccine, API, Cell Separation), Scale of Operation (R&D), End User - Global Forecast to 2030 - Product Thumbnail Image

Tangential Flow Filtration Market by Product (Single Use Systems, Cassettes, Capsules), Material (PES, PVDF), Technique (Ultrafiltration), Application (Protein, Vaccine, API, Cell Separation), Scale of Operation (R&D), End User - Global Forecast to 2030

  • Report
  • August 2025
  • 495 Pages
  • Global
From
Structural Biology & Molecular Modeling Techniques Market - Global Forecast 2026-2032 - Product Thumbnail Image

Structural Biology & Molecular Modeling Techniques Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 191 Pages
  • Global
From
Disposable Flow-Battery Bioreactor Market Report 2026 - Product Thumbnail Image

Disposable Flow-Battery Bioreactor Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
State of the Life Sciences Industry - 2026 First Quarter Review - Product Thumbnail Image

State of the Life Sciences Industry - 2026 First Quarter Review

  • Report
  • April 2026
  • 236 Pages
  • Global
From
Hormone-Refractory Oncology Drug Market Report 2026 - Product Thumbnail Image

Hormone-Refractory Oncology Drug Market Report 2026

  • Report
  • July 2026
  • 250 Pages
  • Global
From
Cancer Immunotherapy Market Report by Products, Application, End Users, Countries and Companies Analysis 2026-2034 - Product Thumbnail Image

Cancer Immunotherapy Market Report by Products, Application, End Users, Countries and Companies Analysis 2026-2034

  • Report
  • June 2026
  • 200 Pages
  • Global
From
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), Product, Payload, Technology, Distribution Channel and Region with Growth Forecasts, 2025-2033 - Product Thumbnail Image

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), Product, Payload, Technology, Distribution Channel and Region with Growth Forecasts, 2025-2033

  • Report
  • November 2025
  • 150 Pages
  • Global
From
Biologics Contract Research Organizations Market Size, Share & Trends Analysis Report by Type, Product, Service, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033 - Product Thumbnail Image

Biologics Contract Research Organizations Market Size, Share & Trends Analysis Report by Type, Product, Service, Therapeutic Area, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Loading Indicator

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies. The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs. Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more